
Leonard A Farber MD
Breast Cancer, Gastrointestinal Cancer, Head & Neck, Skin Cancer
Chief Executive Officer- OncoSphere Health Solutions
Join to View Full Profile
695 Merrick Ave#539Westbury, NY 11590
Phone+1 917-514-9333
Dr. Farber is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Board-certified radiation oncologist and physician-executive entrepreneur with a demonstrated history of building, scaling, and realizing value in oncology ventures.
Proven track record of driving growth in both private and publicly traded companies.
Current Clinical & Strategic Roles:
• Founder & Chief Executive Officer, OncoSphere Health Solutions:
• Chief Medical Officer & Chief Clinical Officer, Cardio Health Solutions
• Chief Medical Officer, Integrative Molecular Solutions
• Chief Strategy Officer, Visionary Oncology
Distinguished Clinical Background:
• Founder & Clinical Director, The Farber Center for Radiation Oncology
• Attending & Professor of Radiation Oncology: Held faculty positions at Memorial Sloan Kettering Cancer Center, City of Hope, and UCLA.
• Former Chairman, Department of Radiation Oncology, Staten Island University Hospital (North Shore/LIJ Health System).
• Past roles include Chief Clinical & Medical Affairs Officer and Chairman of the Scientific Advisory Board at Nanobiotix S.A., Senior Clinical Advisor, PreludeDx, and Senior Medical Director & Section Chief of Radiation Oncology, Care to Care.
Background as an Operating Partner for Vivaris Capital’s Vican Fund provides him with an investor's perspective on Board and advisory roles- The Global Pain Foundation, Genomic Health, Adgero Biopharmaceuticals, Medtronic, BetaGlue Therapeutics SpA.
Education & Credentials:
Board-certified in Radiation Oncology; Residency at the Hospital of the University of Pennsylvania (Chief Resident); MD from Mount Sinai School of Medicine.
Extracurricular Activities
Currently a member of the board of directors of the US Olympic Committee for Bobsled and Skeleton, member of Fraternal Order of Police Surgeons Lodge, Chief Surgeon of the NY State Trooper Police PBA, and member of F. & A.M. Munn Lodge.
Education & Training
University of Pennsylvania Health SystemChief Residency, Radiation Oncology, 1997 - 1998
University of Pennsylvania Health SystemResidency, Radiation Oncology, 1995 - 1997
Icahn School of Medicine at Mount Sinai/Beth IsraelInternship, Internal Medicine, 1994 - 1995
Icahn School of Medicine at Mount SinaiClass of 1994, MD
State University of New YorkBS/BA, 1990
Certifications & Licensure
CA State Medical License 2017 - 2027
NY State Medical License 1998 - 2027
LA State Medical License 2021 - 2023
MI State Medical License 2020 - 2023
NJ State Medical License 2010 - 2019
PA State Medical License 1996 - 2016
CT State Medical License 2009 - 2013
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ, Elekta - IMPAC Medical Systems, Inc., 2012, 2014
- Best Doctors Best Doctors, 2012
- Super Doctors Super Doctors, 2012
Publications & Presentations
PubMed
- 106 citationsClinical Outcomes of Postmastectomy Radiation Therapy After Immediate Breast ReconstructionJigna Desai Jhaveri, Stephen Rush, Karen Kostroff, Dwight C. DeRisi, Leonard A. Farber
International Journal of Radiation Oncology, Biology, Physics. 2008-11-01 - 14 citationsLaparoscopic ovarian transposition to preserve ovarian function before pelvic radiation and chemotherapy in a young patient with rectal cancer.Leonard A. Farber, John W Ames, Stephen Rush, David Gal
Medgenmed. 2005-03-17 - 232 citationsDual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the ...Roland Hustinx, Robin J. Smith, Francois Benard, David I. Rosenthal, Mitchell Machtay
European Journal of Nuclear Medicine. 1999-10-01
Journal Articles
- Comparison of Conventional Versus Conformal External Bean Irradiation of a Stented Coronary Artery Utilizing a New Fluoroscopic Imaging Detector System.Farber LA, Bloch P, York ED, Stevens CW, Herrmann H, Ruffer J, Cardiovascular Radiation Medicine 1(1): 1999;80-85
- Detection of Recurrent Head and Neck Squamous Cell Carcinomas after Radiation Therapy with 218-F-Fluoro-2deoxy-D-glucose Positron Emission Tomography.Farber LA, Bernard F, Machtay M, Alavi A, Smith RJ, Weber RS, Weinstein GS, Rosenthal DI, Laryngoscope 109: 1999;970-975
- Dual Time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the ...Hustinx R, Smith RJ, Bernard F, Rosenthal DI, Machtay M, Farber LA, Alavi A, European Journal of Nuclear Medicine, 26: 1999;1345-1348
Books/Book Chapters
Abstracts/Posters
- Dynamic Contrast Enhanced MRI Of The Prostate Utilizing New Computer Software – An Initial Experience.Berkovich GY, Waldbaum R, Steckel J, Farber LA, Badillo F, Nochomowitz L, American Urological Association New York Section 104th Annual Meeting, New Delhi, India
- Feasibility of Conformal External Beam Irradiation of Stented Coronary Artery.Bloch P, Farber LA, York ED, Ruffer JE, Herrmann H, Proceedings of the Scripps Clinic & Research Foundation- Second Annual Symposium on Radiotherapy...
- The Use of Conformal External Beam Irradiation to Prevent or Reduce Restenosis in a Stented Coronary Artery Following Percutaneous Coronary Angioplasty.Farber LA, Bloch P, York ED, Stevens CW, Herrmann H, Ruffer JE, Advances in Cardiovascular Radiation Therapy Syllabus
Lectures
- Rhabdomyosarcoma of the Nasopharynx.Childrens Hospital of Pennsylvania Cancer Center
- History of Radiotherapy and Review of Intravascular Radiotherapy.6th Annual International Interventional Cardiology Fellows Course, San Jose, CA
- The Management of Pediatrics Medulloblastomas.Hospital of the University of Pennsylvania Cancer Center
Other
- Utilization of a diagnostic related group (DRG) computer system to analyze the frequency of thromboembolic complications in solid tumor malignancies.Farber LA, DiGiovanni G, Bruckner HW, OncoLink
http://www.oncolink.upenn.edu
Press Mentions
NANOBIOTIX Announces Recommended Phase 2 Dose for NBTXR3 in Pancreatic CancerNovember 14th, 2022
NANOBIOTIX Announces First Patient Injected in New Phase 1/2 Study Evaluating Radiotherapy-Activated NBTXR3 plus Anti-PD-1 for Patients with Advanced CancersJuly 20th, 2023
Other Languages
- Spanish, Chinese (Mandarin), Russian, Chinese (Cantonese)
External Links
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









